Evaluation of the safety and efficacy with asenapine sublingual tablets in acute clinical settings in patients with schizophrenia‐final report on post‐marketing surveillance study

収録刊行物

• Jpn J Clin Psychopharmacol

  Jpn J Clin Psychopharmacol 24 (7), 751-, 2021